Following the adaptation of the European production standard EU-GMP, Panaxia will start production in the local facility in Malta. Obtaining the license allows.
- Net Israeli revenues in 2021 increased 38% to 83.6 million. - Initial revenues from medical cannabis oils export from Israel, which began at the end of 2020,.
/PRNewswire/ Panaxia Labs Israel Ltd. ("Panaxia Israel"), (TASE: PNAX), a global pharma company which develops, manufactures and markets progressive medical.
Panaxia and Neuraxpharm: First export of medical cannabis sublingual tablets to France medindia.net - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from medindia.net Daily Mail and Mail on Sunday newspapers.
/PRNewswire/ Panaxia Global, the controlling owner of Panaxia Labs Israel Ltd. (TASE: PNAX), a global pharma company that develops, manufactures and markets.